Monday, Dec 05, 2022 | Last Update : 03:28 AM IST

AstraZeneca Page-2

AstraZeneca's Lynparza shown to put brakes on ovarian cancer

Given as a maintenance therapy to reinforce initial chemotherapy, Lynparza halted or reversed tumour growth in 60 percent of patients.

22 Oct 2018 8:54 AM

Pfizer shares surge after AstraZeneca deal

The shares surged over 7 per cent after the company entered into a pact.

01 Jun 2017 12:36 PM

ADVERTISEMENT
ADVERTISEMENT